Covered recipient · General Payments record
AMANDA F DUNN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2022–2024
$319.39
- Reported across 18 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $182.76 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $59.63 | 3 |
| Lilly USA, LLC | $47.49 | 3 |
| Acerta Pharma LLC | $29.28 | 2 |
| ABBVIE INC. | $17.59 | 1 |
| Astellas Pharma US Inc | $14.46 | 1 |
| Phathom Pharmaceuticals, Inc. | $14.31 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.59 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107049534 | CMS |
| Amgen Inc. | $24.34 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117545974 | CMS |
| Amgen Inc. | $13.16 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115590427 | CMS |
| Amgen Inc. | $22.13 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115590436 | CMS |
| Astellas Pharma US Inc | $14.46 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139500408 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.19 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104240917 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.09 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104455992 | CMS |
| Lilly USA, LLC | $14.37 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135523049 | CMS |
| Lilly USA, LLC | $15.57 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135464168 | CMS |
| Lilly USA, LLC | $17.55 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135528517 | CMS |
| Phathom Pharmaceuticals, Inc. | $14.31 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151162386 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.